Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025MBX 1416 Phase 2 trial in ...
After hours: March 21 at 4:14:17 PM EDT Loading Chart for MBX ...
After hours: March 20 at 5:27:54 p.m. EDT Loading Chart for MBX ...
After hours: March 20 at 4:05:11 PM EDT Loading Chart for BCAX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback